Online Only Articles

Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells

Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba;Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba
Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto
Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba;Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
Department of Clinical Biology and Medicine, Chiba University Graduate School of Medicine, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Department of Hematology, Chiba University Hospital, Chiba
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2018.214841